Josep Llorens - 23 Jan 2023 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
EVP, Global Manufacturing
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Llorens
Issuer symbol
HAE
Transactions as of
23 Jan 2023
Net transactions value
-$79,931
Form type
4
Filing time
25 Jan 2023, 15:28:42 UTC
Previous filing
07 Sep 2022
Next filing
16 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Options Exercise $135,259 +2,391 +14% $56.57 19,625 23 Jan 2023 Direct F1, F2
transaction HAE Common Stock Sale $215,190 -2,391 -12% $90.00 17,234 23 Jan 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HAE Non-qualified Stock Option (Right to Buy) Options Exercise $0 -2,391 -25% $0.000000 7,173 23 Jan 2023 Common Stock 2,391 $56.57 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction pursuant to an existing 10b5-1 trading plan.
F2 This number includes unvested restricted stock units previously reported.
F3 Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.